Recombinant IL-1 beta antibody
Quick Overview for Recombinant IL-1 beta antibody (ABIN7581490)
Target
See all IL-1 beta (IL1B) AntibodiesAntibody Type
Reactivity
Host
Clonality
Conjugate
Application
Clone
- 
    
- 
                                            
Expression System
 - CHO Cells
 - 
                                            
Purpose
 - Anti-IL-1b Reference Antibody (CDP484)
 - 
                                            
Characteristics
 - Anti-IL-1b Reference Antibody (CDP484) is expressed from CHO. The heavy chain type is huIgG1, and the light chain type is hukappa. It has a predicted MW of 145.5 kDa.
 - 
                                            
Purity
 - >95 %
 - 
                                            
Isotype
 - IgG1
 
 - 
                                            
 - 
    
 - 
    
- 
                                            
Application Notes
 - Optimal working dilution should be determined by the investigator.
 - 
                                            
Restrictions
 - For Research Use only
 
 - 
                                            
 - 
    
- 
                                            
Format
 - Lyophilized
 - 
                                            
Concentration
 - 1 mg/mL
 - 
                                            
Buffer
 - 25 mM histidine, 8 % sucrose, 0.01 % Tween80 pH 6.2
 - 
                                            
Storage
 - 4 °C,-80 °C
 - 
                                            
Storage Comment
 - +4°C,-80°C
 
 - 
                                            
 - 
    
- IL-1 beta (IL1B) (Interleukin 1, beta (IL1B))
 - 
                                            
Alternative Name
 - IL-1b
 - 
                                            
Molecular Weight
 - 145.5 kDa
 - 
                                            
UniProt
 - P01584
 - 
                                            
Pathways
 - NF-kappaB Signaling, Interferon-gamma Pathway, TLR Signaling, Negative Regulation of Hormone Secretion, Cellular Response to Molecule of Bacterial Origin, Carbohydrate Homeostasis, Glycosaminoglycan Metabolic Process, Myometrial Relaxation and Contraction, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Autophagy, Cancer Immune Checkpoints, Inflammasome
 
Target
 -